Open access
1,056
Views
0
CrossRef citations to date
0
Altmetric
Research article
Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)
Ozan S. Kumrua Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USAView further author information
, Sakshi Bajoriaa Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USAView further author information
, Kawaljit Kaura Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USAView further author information
, John M. Hickeya Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USAView further author information
, Greta Van Slykeb Division of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY, USAView further author information
, Jennifer Doeringb Division of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY, USAView further author information
, Katherine Bermanb Division of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY, USAView further author information
, Charles Richardsonc Technical Operations, Icosavax, Seattle, WA, USAView further author information
, Hans Liend Quality, Icosavax, Seattle, WA, USAView further author information
, Harry Kleanthouse Discovery & Translational Sciences, Global Health, Bill and Melinda Gates Foundation, Seattle, WA, USAView further author information
, Nicholas J. Mantisb Division of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY, USAView further author information
, Sangeeta B. Joshia Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USAView further author information
& David B. Volkina Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USACorrespondence[email protected]
View further author information
show allView further author information
Article: 2264594
|
Received 13 Jul 2023, Accepted 25 Sep 2023, Published online: 06 Nov 2023
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.